ArticleAmerican journal of translational research2025

FOLFOX-HAIC combined with PD-1 inhibitor immunotherapy significantly improves survival in patients with advanced hepatocellular carcinoma.

Jinzhen Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.